Urology
News, opinions and meeting coverage in urology.
Latest in Urology
Investigational intravesical solution led to complete response rate of 79%
Study validates concerns about benign prostatic hyperplasia-related PSMA-PET false positives
Potential standard of care after current therapies, but key obstacles remain in the way
Building on recent success requires intervention at multiple steps in the cancer immunity cycle
Potential standard of care after current therapies, but key obstacles remain in the way
Building on recent success requires intervention at multiple steps in the cancer immunity cycle
More in Urology
Responses to "special drug" zanzalintinib in cabozantinib-exposed and unexposed patients



Treatment over 1 to 2 weeks achieves similar outcomes to therapy given for as long as 7.5 weeks

Nedosiran approved for patients ages 9 years and older with primary hyperoxaluria type 1
